AGC Pharma Chemicals Validates New Barcelona CDMO Facility Through Scientist.com’s VERIF.i® Supplier Assessment Program AGC Pharma Chemicals, a leading global Contract Development and Manufacturing Organization (CDMO) specializing in small molecule active pharmaceutical ingredients (APIs) and highly potent active pharmaceutical ingredients…
Caidya and Simbec-Orion Combine to Create Global Specialty CRO Platform Spanning Early-Phase Research Through Late-Stage Clinical Development Caidya has announced a strategic combination with Simbec-Orion, marking a significant step in the evolution of both organizations as they seek to deliver…
FNIH and Leading Advocates Launch Music as Medicine Neuroscience Initiative The Foundation for the National Institutes of Health (FNIH) has announced the launch of the Music as Medicine Neuroscience Research Initiative, a new program designed to accelerate scientific research into…
Croma-Pharma Secures FDA Approval for Obagi saypha® ChIQ™ to Expand Facial Aesthetic Treatment Options in the U.S. Croma-Pharma has reached another significant milestone in its global growth strategy with the U.S. Food and Drug Administration (FDA) approving Obagi saypha® ChIQ™,…
Caidya and Simbec-Orion Unite to Create Global Specialty CRO for End-to-End Drug Development Caidya has announced a strategic combination with Simbec-Orion, marking a significant milestone in the clinical research industry by creating a global specialty contract research organization (CRO) designed…
Feinstein Institutes Uncover Ancient Reflex Linked to Future Brain Injury Therapies Researchers at Northwell Health’s Feinstein Institutes for Medical Research have uncovered the molecular mechanism behind one of the body’s oldest survival responses—the diving reflex—providing new insights that could transform…
Incyte Receives Positive CHMP Opinion for Opzelura® Cream in Adults with Moderate Atopic Dermatitis Incyte has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the…
Elevation Spine Surpasses 5,000 Saber-C Implantations, Highlighting Growing Adoption of Its Integrated Cervical Fusion Technology Elevation Spine has announced a significant milestone for its cervical spine portfolio, revealing that more than 5,000 Saber-C Anterior Cervical Fusion System implantations have now…
AL-S Pharma Presents Phase 2 AP-101 Data at ENCALS 2026, Highlighting Potential Disease-Modifying Effects in ALS AL-S Pharma AG, a clinical-stage biotechnology company focused on developing antibody therapies against misfolded proteins associated with amyotrophic lateral sclerosis (ALS), has presented new…
VectorBuilder and MaxCyte Partner to Develop Next-Generation Non-Viral Gene Delivery Platform for Ex Vivo Cell Therapies VectorBuilder and MaxCyte have entered into a strategic partnership aimed at developing a next-generation non-viral gene delivery platform for ex vivo cell engineering, a…
AdvanCell Establishes U.S. Global Headquarters in Greater Boston, Expands Manufacturing Footprint to Support Radiopharmaceutical Growth AdvanCell, a clinical-stage radiopharmaceutical company focused on developing targeted alpha therapies for cancer, has announced a major step in its global expansion strategy with the…
Syntax Bio Expands Series A to $14.4 Million, Strengthens Leadership Team and Advances Cell Programming Platform for Type 1 Diabetes Therapies Syntax Bio, a synthetic biology company focused on programming the next generation of cell therapies, has announced a significant…